Aditxt adjourns special meeting to Feb 13 for reverse split, name change, equity plan votes

Aditxt, Inc.

Special meeting adjourned to Feb 13, 2026 at 12 PM ET to allow more stockholder voting time.
Proposals include approval of shares issuance under Series A-1 and C-1 convertible preferred and warrants from 2023-2024.
Stockholders to vote on 2025 ESPP and amendment to 2021 Omnibus Plan to increase authorized shares from 3 to 350,000.
Non-binding advisory vote on corporate name change from Aditxt to bitXbio, Inc.
Board seeks authority for reverse stock split at ratio between 1:5 and 1:250, effective within one year of approval.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.